News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,183 Results
Type
Article (60402)
Company Profile (641)
Press Release (674122)
Multimedia
Podcasts (169)
Webinars (27)
Section
Business (192705)
Career Advice (3023)
Deals (35059)
Drug Delivery (165)
Drug Development (81236)
Employer Resources (176)
FDA (17929)
Job Trends (15407)
News (337865)
Policy (36043)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2906)
Academic (1)
Accelerated approval (48)
Adcomms (37)
Allergies (176)
Alliances (49946)
ALS (211)
Alzheimer's disease (1879)
Antibody-drug conjugate (ADC) (463)
Approvals (18185)
Artificial intelligence (708)
Autoimmune disease (260)
Automation (55)
Bankruptcy (349)
Best Places to Work (11987)
BIOSECURE Act (23)
Biosimilars (229)
Biotechnology (410)
Bladder cancer (187)
Brain cancer (72)
Breast cancer (734)
Cancer (5823)
Cardiovascular disease (505)
Career advice (2569)
Career pathing (47)
CAR-T (328)
CDC (73)
Celiac Disease (2)
Cell therapy (895)
Cervical cancer (46)
Clinical research (69966)
Collaboration (2109)
Company closure (6)
Compensation (1340)
Complete response letters (100)
COVID-19 (2979)
CRISPR (112)
C-suite (1085)
Cystic fibrosis (159)
Data (7549)
Decentralized trials (3)
Denatured (43)
Depression (181)
Dermatology (71)
Diabetes (597)
Diagnostics (7235)
Digital health (56)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (342)
Drug pricing (237)
Drug shortages (36)
Duchenne muscular dystrophy (289)
Earnings (80552)
Editorial (75)
Employer branding (21)
Employer resources (154)
Events (115584)
Executive appointments (1074)
FDA (21623)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1728)
Gene editing (240)
Generative AI (66)
Gene therapy (755)
GLP-1 (1197)
Government (5311)
Grass and pollen (8)
Guidances (405)
Healthcare (19811)
HIV (84)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (334)
Immuno-oncology (98)
Indications (165)
Infectious disease (3342)
Inflammatory bowel disease (216)
Inflation Reduction Act (15)
Influenza (143)
Intellectual property (285)
Interviews (572)
IPO (16656)
IRA (59)
Job creations (3806)
Job search strategy (2096)
JPM (72)
Kidney cancer (20)
Labor market (98)
Layoffs (653)
Leadership (47)
Legal (8553)
Liver cancer (105)
Longevity (29)
Lung cancer (776)
Lymphoma (420)
Machine learning (59)
Management (58)
Manufacturing (1042)
MASH (193)
Medical device (14707)
Medtech (14794)
Mergers & acquisitions (19645)
Metabolic disorders (1604)
mRNA (225)
Multiple sclerosis (186)
NASH (23)
Neurodegenerative disease (437)
Neuropsychiatric disorders (120)
Neuroscience (3443)
Neurotech (2)
NextGen: Class of 2026 (7078)
Non-profit (4721)
Now hiring (48)
Obesity (786)
Opinion (337)
Ovarian cancer (212)
Pain (261)
Pancreatic cancer (288)
Parkinson's disease (370)
Partnered (34)
Patents (590)
Patient recruitment (650)
Peanut (65)
People (56993)
Pharmaceutical (114)
Pharmacy benefit managers (35)
Phase 1 (21379)
Phase 2 (30511)
Phase 3 (23523)
Pipeline (7817)
Policy (372)
Postmarket research (2886)
Preclinical (9178)
Press Release (71)
Prostate cancer (300)
Psychedelics (65)
Radiopharmaceuticals (333)
Rare diseases (1131)
Real estate (6218)
Recruiting (74)
Regulatory (27687)
Reports (53)
Research institute (2632)
Resumes & cover letters (496)
Rett syndrome (35)
RNA editing (25)
RSV (96)
Schizophrenia (185)
Series A (290)
Series B (215)
Service/supplier (23)
Sickle cell disease (116)
Special edition (30)
Spinal muscular atrophy (178)
Sponsored (52)
Startups (3724)
State (2)
Stomach cancer (21)
Supply chain (133)
Tariffs (104)
The Weekly (124)
Vaccines (1235)
Venture capital (114)
Weight loss (544)
Women's health (118)
Worklife (24)
Date
Today (114)
Last 7 days (789)
Last 30 days (2835)
Last 365 days (31923)
2026 (10282)
2025 (32022)
2024 (36776)
2023 (41249)
2022 (52483)
2021 (57042)
2020 (55607)
2019 (48334)
2018 (36849)
2017 (34452)
2016 (34039)
2015 (38835)
2014 (31195)
2013 (26109)
2012 (28285)
2011 (28660)
2010 (26288)
Location
Africa (977)
Alabama (97)
Alaska (7)
Arizona (321)
Arkansas (14)
Asia (43703)
Australia (7618)
California (12931)
Canada (3558)
China (1307)
Colorado (546)
Connecticut (575)
Delaware (387)
Europe (102308)
Florida (1918)
Georgia (420)
Hawaii (4)
Idaho (63)
Illinois (1057)
India (91)
Indiana (575)
Iowa (25)
Japan (521)
Kansas (129)
Kentucky (47)
Louisiana (44)
Maine (85)
Maryland (1583)
Massachusetts (9340)
Michigan (341)
Minnesota (709)
Mississippi (6)
Missouri (158)
Montana (30)
Nebraska (28)
Nevada (144)
New Hampshire (89)
New Jersey (3469)
New Mexico (29)
New York (3380)
North Carolina (1746)
North Dakota (10)
Northern California (6370)
Ohio (391)
Oklahoma (22)
Oregon (49)
Pennsylvania (2535)
Puerto Rico (29)
Rhode Island (47)
South America (1343)
South Carolina (85)
South Dakota (2)
Southern California (5066)
Tennessee (201)
Texas (2042)
United States (45946)
Utah (378)
Vermont (1)
Virginia (325)
Washington D.C. (85)
Washington State (1065)
West Virginia (4)
Wisconsin (146)
Wyoming (2)
735,183 Results for "amplifon s p a us headquarters".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
March 16, 2026
·
12 min read
Press Releases
WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial
March 20, 2026
·
2 min read
Press Releases
PharmaTher’s Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides
U.S. regulatory momentum in psychedelics and peptides could open new commercial opportunities for PharmaTher’s PatchPrint™ automated manufacturing platform and PharmaPatch™ product platform as an attractive solution for compounding pharmacies, hospitals, research institutions, and commercial partners
April 20, 2026
·
8 min read
Press Releases
PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
Company believes supportive U.S. policy momentum may strengthen the strategic value of its ketamine patch, KetaVault™ platform, retained ketamine programs, and prior FDA-approved ketamine ANDA transaction
April 21, 2026
·
1 min read
Job Trends
Report: 2026 U.S. Life Sciences Salary Report
BioSpace
‘s 2026 U.S. Life Sciences Salary Report delivers a comprehensive look at how salaries, bonuses and benefits evolved over the past year amid ongoing economic pressure and workforce recalibration. It uncovers not just what people are earning, but how they’re thinking about compensation, career moves and total rewards in 2026.
March 19, 2026
·
1 min read
·
BioSpace Insights
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company’s Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder, PTSD, and traumatic brain injury
April 20, 2026
·
6 min read
GLP-1
Lilly, Baseline Investigate GLP-1s’ Potential in Substance Use as Interest Mounts
Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists in treating substance use disorders.
March 30, 2026
·
6 min read
·
Catherine Offord
Press Releases
Model Medicines Granted First U.S. Patent related to MDL-001 in its Broad Antiviral Intellectual Property Portfolio
Model Medicines’ antiviral intellectual property portfolio encompasses 15 patent families covering novel compositions of matter, multi-scaffold Markush chemistry, formulations, and broad-spectrum methods of use across RNA and DNA viruses
April 16, 2026
·
1 min read
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
In the U.S., Moderna withdrew its approval application for the combination vaccine in May last year and the timeline for resubmission remains uncertain.
April 22, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
1 of 73,519
Next
